Bemarituzumab Antibody
Bemarituzumab is a humanized monoclonal IgG1 antibody designed to inhibit FGFR2b signaling by blocking FGF ligand binding. Its application in cancer research includes targeting FGFR2b-overexpressing tumors, such as gastric and breast cancers, in both in vitro cell-based assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
FGFR, FPA144, FPA-144, FPA 144, Bemarituzumab
Target
FGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
3.55 mg/mL
Purity
100.00% (May vary between batches)
Molecular Weight
144 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-D433968-250MG 250 mg
1-(3,4-Difluorophenyl)-3-nitro-1-propanone
Sign In for Pricing
View Details 
BNUM1829-50 1x 50 µL
CD20 / MS4A1 (B-Cell Marker) (rIGEL/773), 1mg/mL
Sign In for Pricing
View Details 
